The Wisnivesky Laboratory research focuses in two areas: the assessment and improvement of self-management of chronic lung disease, primarily asthma and chronic obstructive pulmonary disease (COPD), and the development of treatment recommendations for lung and other cancers using large dataset analyses.
Major ongoing efforts include observational and pilot intervention studies in asthma and COPD morbidity, including quality of life, symptom perception, disease beliefs, medication adherence, and intersection with chronic comorbidities. We utilize validated survey instruments, lung function tests, biomarker analyses and self-management behavior tracking devices to inform the pilot interventions in these studies with the aim of improving both self-management and outcomes in these populations.
Additionally, there are several projects that are examining outcomes of lung cancer patients with from national cancer registries. The goal in these studies is to develop treatment recommendations and inform the development of guidelines to improve patient outcomes.
Our laboratory collaborates with other research groups within Mount Sinai, in the New York metropolitan area and throughout the United States.